A Study of the Safety and Efficacy of AGN-214868 in Patients With Postherpetic Neuralgia

NCT01129531 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

294

Enrollment

INDUSTRY

Sponsor class

Conditions

Neuralgia, Postherpetic

Interventions

DRUG: AGN-214868
DRUG: Placebo to AGN-214868

Sponsor

Allergan